These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1657076)

  • 41. Germ-cell tumors of the testis: improved results in a prospective study using combined modality therapy and biochemical tumor markers.
    Scardino PT; Skinner DG
    Surgery; 1979 Jul; 86(1):86-93. PubMed ID: 88077
    [No Abstract]   [Full Text] [Related]  

  • 42. Testicular cancer: Long-term outcomes of single BEP cycle.
    Kelsey R
    Nat Rev Urol; 2015 Jan; 12(1):7. PubMed ID: 25447833
    [No Abstract]   [Full Text] [Related]  

  • 43. Targeted therapies in germ cell tumors.
    Squillante CM; Vaughn DJ
    Urol Oncol; 2015 Aug; 33(8):363-9. PubMed ID: 25544153
    [No Abstract]   [Full Text] [Related]  

  • 44. Understanding the somatic-type malignant differentiation in male germ-cell cancer: a work in progress. Response to the article by Spiess et al., Malignant transformation of testicular teratoma: a chemoresistant phenotype. Urol Oncol 2008;26:595-9.
    Necchi A; Nicolai N; Colecchia M; Salvioni R
    Urol Oncol; 2009; 27(2):218; author reply 218-9. PubMed ID: 19285238
    [No Abstract]   [Full Text] [Related]  

  • 45. [Platinum antitumor complexes].
    Bonetti A; Giuliani J; Muggia F
    Recenti Prog Med; 2015 Dec; 106(12):618-28. PubMed ID: 26780071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Decreased pulmonary toxicity in continuous subcutaneous infusion and consecutive daily injection of peplomycin in testicular tumor patients].
    Satake I; Tari K; Suzuki F; Yoshida S
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2291-7. PubMed ID: 2420909
    [No Abstract]   [Full Text] [Related]  

  • 47. [Cisplatin in the treatment of testicular carcinoma].
    van Groeningen CJ; Pinedo HM
    Ned Tijdschr Geneeskd; 1986 Nov; 130(44):1980-4. PubMed ID: 3022163
    [No Abstract]   [Full Text] [Related]  

  • 48. Adjuvant chemotherapy for testicular cancer.
    Logothetis CJ
    N Engl J Med; 1988 Jul; 319(1):53. PubMed ID: 2837667
    [No Abstract]   [Full Text] [Related]  

  • 49. The role of ifosfamide in the treatment of nonseminomatous testicular cancer.
    Scheulen ME; Niederle N; Kath R; Wandl UB; Seeber S; Schmidt CG
    Prog Clin Biol Res; 1988; 269():439-50. PubMed ID: 2455912
    [No Abstract]   [Full Text] [Related]  

  • 50. High-dose chemotherapy in nonseminomatous germ cell cancer.
    Kollmannsberger C; Beyer J; Bokemeyer C
    BJU Int; 2009 Nov; 104(9 Pt B):1398-403. PubMed ID: 19840020
    [No Abstract]   [Full Text] [Related]  

  • 51. Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model.
    Jørgensen A; Blomberg Jensen M; Nielsen JE; Juul A; Rajpert-De Meyts E
    J Steroid Biochem Mol Biol; 2013 Jul; 136():238-46. PubMed ID: 23098692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase II study of oral medroxyprogesterone acetate in advanced germ cell tumors.
    Cavalli F; Klepp O; Hansen H; Rozencweig M
    Cancer Treat Rep; 1983 Oct; 67(10):953-4. PubMed ID: 6313188
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of locoregional germ cell tumor.
    Herr HW
    Prog Clin Biol Res; 1990; 350():295-9. PubMed ID: 2166959
    [No Abstract]   [Full Text] [Related]  

  • 54. [Prolonged regression of metastatic tumors of the testis: rejections on prognosis].
    Gayet R; Cabanne F; Guerrin J
    J Urol Nephrol (Paris); 1976; 82(10-11):913-6. PubMed ID: 187807
    [No Abstract]   [Full Text] [Related]  

  • 55. Bleomycin in germ cell testicular tumors (GCTT).
    Germa Lluch JR
    Prog Clin Biol Res; 1985; 203():381-9. PubMed ID: 2421332
    [No Abstract]   [Full Text] [Related]  

  • 56. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
    Hartmann JT; Gauler T; Metzner B; Gerl A; Casper J; Rick O; Horger M; Schleicher J; Derigs G; Mayer-Steinacker R; Beyer J; Kuczyk MA; Bokemeyer C;
    J Clin Oncol; 2007 Dec; 25(36):5742-7. PubMed ID: 18089869
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of patients with disseminated testicular germ cell tumors].
    Protsenko SA; Semenova AI; Novik AV; Teletaeva GM; Latipova DKh; Komarov YI; Nosov AK; Levchenko EV; Gafton GI; Semenov II; Klimashevsky VF
    Vopr Onkol; 2015; 61(2):289-96. PubMed ID: 26087613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physical activity in long-term survivors of germ-cell cancer.
    Sleijfer S; de Wit R
    Eur J Cancer; 2003 Jun; 39(9):1191-3. PubMed ID: 12763205
    [No Abstract]   [Full Text] [Related]  

  • 59. Growth and chemotherapy of a human germ-cell tumour line (GCT 27).
    Schlappack OK; Bush C; Delic JI; Steel GG
    Strahlenther Onkol; 1989 Jul; 165(7):541. PubMed ID: 2473535
    [No Abstract]   [Full Text] [Related]  

  • 60. Re: First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG).
    Richie JP
    J Urol; 2015 Mar; 193(3):850. PubMed ID: 25765390
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.